Clinical observation, waist circumference, and patient-reported changes across sleep, energy, and recovery give a more complete picture of how the protocol is actually working
Monthly 1,000 mcg Maintenance Protocol Once the deficiency is fixed, a monthly maintenance protocol of 1,000 mcg injections is suggested
One such anti-obesity medication cum peptide that we are talking about today is AOD9604
5-amino-1MQ did not inhibit SIRT1 concentrations ranging from 10 nM 300 M, and minor reduction in SIRT1 activity was observed with 600 M 5-amino-1MQ (Figure 4E)
In clinical contexts, AOD 9604 has also been evaluated in obesity-related trials, where ongoing work continues to assess its potential role